Your browser doesn't support javascript.
loading
Overexpression of heat shock protein 47 is associated with increased proliferation and metastasis in gastric cancer.
Lee, Jieun; Hwang, Jung-Ah; Hong, Seung-Hyun; Kim, Seon-Young; Seol, Donghyeok; Choi, Il Ju; Lee, Yeon-Su.
Afiliação
  • Lee J; Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
  • Hwang JA; Genomics Core Facility, Research Core Center, Research Institute, National Cancer Center, Goyang, Republic of Korea.
  • Hong SH; Genomics Core Facility, Research Core Center, Research Institute, National Cancer Center, Goyang, Republic of Korea.
  • Kim SY; Enzynomics Co. Ltd, Daejeon, Republic of Korea.
  • Seol D; Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
  • Choi IJ; Center for Gastric Cancer, National Cancer Center, Goyang, Republic of Korea.
  • Lee YS; Rare Cancer Branch, Research Institute, National Cancer Center, Goyang, Republic of Korea. yslee2@ncc.re.kr.
Genomics Inform ; 22(1): 6, 2024 Jun 17.
Article em En | MEDLINE | ID: mdl-38907287
ABSTRACT
Here, we investigated that the heat shock protein 47 (HSP47) plays a crucial role in the progression of gastric cancer (GC). We analyzed HSP47 gene expression in GC cell lines and patient tissues. The HSP47 mRNA and protein expression levels were significantly higher in GC cell lines and tumor tissues compared to normal gastric mucosa. Using siRNA to silence the expression of HSP47 in GC cells resulted in a significant reduction in their proliferation, wound healing, migration, and invasion capacities. Additionally, we also showed that the mRNA expression of matrix metallopeptidase-7 (MMP-7), a metastasis-promoting gene, was significantly reduced in HSP47 siRNA-transfected GC cells. We confirmed that the HSP47 promoter region was methylated in the SNU-216 GC cell line expressing low levels of HSP47 and in most non-cancerous gastric tissues. It means that the expression of HSP47 is regulated by epigenetic regulatory mechanisms. These findings suggest that targeting HSP47, potentially through its promoter methylation, could be a useful new therapeutic strategy for treating GC.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article